Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Stanford University
Rigshospitalet, Denmark
University of Colorado, Denver
Dana-Farber Cancer Institute
Rigshospitalet, Denmark
Assistance Publique - Hôpitaux de Paris
Fred Hutchinson Cancer Center
Shenzhen University General Hospital
Masonic Cancer Center, University of Minnesota
Baptist Health South Florida
Rigshospitalet, Denmark
University of Rochester
Stanford University
University of Illinois at Chicago
University of California, San Francisco
Phoenix Children's Hospital
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Children's Hospital of Michigan
Baylor College of Medicine
University of Erlangen-Nürnberg Medical School
Stanford University
M.D. Anderson Cancer Center
Beth Israel Deaconess Medical Center
M.D. Anderson Cancer Center
Baylor College of Medicine
Peking University
Copenhagen University Hospital at Herlev
M.D. Anderson Cancer Center